Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Post by carduon Dec 24, 2011 1:46pm
452 Views
Post# 19350823

Thanks for the info Sharkfood.

Thanks for the info Sharkfood.

I tried three times to send the e-mail below to the Oncolytics site and each one came back as undeliverable. I wonder (hopefully) if they have had a deluge of negative e-mails regarding the options and decided to suspend the site.

 
To Nick Hurst
 
It would seem that the main contact address for ONC is not available for comment. Perhaps you would be kind enough to pass on my comments below to the appropriate individual.
 
Sir
 
As a long term investor in ONC (nine years) I would be interested in someone explaining to me why a raft of overly generous options have been granted to the officers and directors of my company while the share price has plummeted by 50% in one year. I was always under the impression (apparently naively) that executive compensation was supposed to be linked to shareholder value.
 
One of the Canadian Coalition for Good Governance's requirement is that the CEO and the Chairman of the Board should not be the same individual. Perhaps, as this is not the case with ONC, this explains the issuance of the excessive options. The board is supposed to monitor the actions of management.
 
Sincerely
 
XXXXXXXXX 

 

Bullboard Posts